20-63981287-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_012469.4(PRPF6):c.42C>T(p.Pro14Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000574 in 1,607,534 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00065 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00057 ( 12 hom. )
Consequence
PRPF6
NM_012469.4 synonymous
NM_012469.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.694
Genes affected
PRPF6 (HGNC:15860): (pre-mRNA processing factor 6) The protein encoded by this gene appears to be involved in pre-mRNA splicing, possibly acting as a bridging factor between U5 and U4/U6 snRNPs in formation of the spliceosome. The encoded protein also can bind androgen receptor, providing a link between transcriptional activation and splicing. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 20-63981287-C-T is Benign according to our data. Variant chr20-63981287-C-T is described in ClinVar as [Benign]. Clinvar id is 339461.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63981287-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.694 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.000566 (823/1455198) while in subpopulation EAS AF= 0.0189 (747/39450). AF 95% confidence interval is 0.0178. There are 12 homozygotes in gnomad4_exome. There are 412 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 99 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRPF6 | NM_012469.4 | c.42C>T | p.Pro14Pro | synonymous_variant | 1/21 | ENST00000266079.5 | NP_036601.2 | |
PRPF6 | XM_006723769.4 | c.42C>T | p.Pro14Pro | synonymous_variant | 1/20 | XP_006723832.1 | ||
PRPF6 | XR_007067448.1 | n.156C>T | non_coding_transcript_exon_variant | 1/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRPF6 | ENST00000266079.5 | c.42C>T | p.Pro14Pro | synonymous_variant | 1/21 | 1 | NM_012469.4 | ENSP00000266079.4 |
Frequencies
GnomAD3 genomes AF: 0.000650 AC: 99AN: 152218Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
99
AN:
152218
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00160 AC: 373AN: 233556Hom.: 7 AF XY: 0.00153 AC XY: 195AN XY: 127218
GnomAD3 exomes
AF:
AC:
373
AN:
233556
Hom.:
AF XY:
AC XY:
195
AN XY:
127218
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000566 AC: 823AN: 1455198Hom.: 12 Cov.: 31 AF XY: 0.000570 AC XY: 412AN XY: 723362
GnomAD4 exome
AF:
AC:
823
AN:
1455198
Hom.:
Cov.:
31
AF XY:
AC XY:
412
AN XY:
723362
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000650 AC: 99AN: 152336Hom.: 4 Cov.: 33 AF XY: 0.000738 AC XY: 55AN XY: 74500
GnomAD4 genome
AF:
AC:
99
AN:
152336
Hom.:
Cov.:
33
AF XY:
AC XY:
55
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
16
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Retinal dystrophy Benign:1
Benign, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Retinitis pigmentosa Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at